Osama Alsaleh Joins CureSearch Board of Directors to Advance Pediatric Oncology Innovation and Strategic Partnerships
admin CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to ending childhood cancer by...
Uncategorized
The Resilience of Lauren Kate: Navigating B-Cell Acute Lymphoblastic Leukemia and the Intersection of Childhood Cancer and Down Syndrome
The landscape of pediatric oncology is often defined by stories of profound courage, and the...
CureSearch Announces 2026 Community Impact Awards to Strengthen Psychosocial Support for Pediatric Cancer Patients and Families
CureSearch for Children’s Cancer, a leading national non-profit dedicated to accelerating the development of pediatric...
The Legacy of David Benyo: How a Childhood Friendship and a 25-Mile Trek Are Fueling the Fight Against Pediatric Cancer
The landscape of pediatric oncology is often defined by statistics, clinical trials, and survival rates,...
Resilient Siblings Overcome Hereditary Bilateral Retinoblastoma Amidst Advocacy and Medical Challenges
The narrative of Jaylen and Ayla, two young survivors of hereditary bilateral retinoblastoma, serves as...
CureSearch Awards $2M for Neuroblastoma CAR T-Cell Therapy Trial
CureSearch for Children’s Cancer, a leading global nonprofit dedicated to accelerating the development of new...
Resilient Journey through Pediatric Cancer Amari’s Path from Diagnosis to Survivorship during National Cancer Survivors Month
The trajectory of a family’s life can be fundamentally altered in the span of a...
CureSearch for Children’s Cancer Appoints Healthcare Innovation Leader Osama Alsaleh to Board of Directors
CureSearch for Children’s Cancer, a leading national nonprofit foundation dedicated to accelerating the development of...
CureSearch for Children’s Cancer Awards $2 Million to Washington University for Innovative Pediatric Brain Cancer Immunotherapy Trial
CureSearch for Children’s Cancer, a leading global nonprofit focused on accelerating the development of new...
Breakthrough Immunotherapy for High-Risk Neuroblastoma: Dr. Hunter Jonus Leads Innovative Gamma Delta T Cell Research at Emory University
Neuroblastoma represents the most frequently diagnosed extracranial solid tumor in the pediatric population, originating within...
